Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Byhardt

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Radiology|September 1, 1982
Advanced carcinoma of the nasopharynx. A clinical study of 274 patientsZ Petrovich, J D Cox, B Roswit, et al.
Cancer|May 1, 1995
Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15R W Byhardt, C B Scott, D S Ettinger, et al.
Journal of the National Cancer Institute|February 1, 1995
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancerW T Sause, C Scott, S Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trialsJ D Cox, C B Scott, R W Byhardt, et al.
American Journal of Clinical Oncology|November 5, 1997
Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06R Komaki, C Scott, J S Lee, et al.
American Journal of Clinical Oncology|October 1, 1985
Characteristics of long-term survivors after treatment for inoperable carcinoma of the lungR Komaki, J D Cox, A J Hartz, et al.
American Journal of Clinical Oncology|April 1, 1992
Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04W T Sause, C Scott, S Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1989
Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trialJ R Simpson, M Bauer, C A Perez, et al.
Cancer|August 11, 1991
Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11W J Curran, J D Cox, N Azarnia, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1993
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433R Komaki, T F Pajak, R W Byhardt, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Radiology|September 1, 1982
Advanced carcinoma of the nasopharynx. A clinical study of 274 patientsZ Petrovich, J D Cox, B Roswit, et al.
Cancer|May 1, 1995
Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15R W Byhardt, C B Scott, D S Ettinger, et al.
Journal of the National Cancer Institute|February 1, 1995
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancerW T Sause, C Scott, S Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trialsJ D Cox, C B Scott, R W Byhardt, et al.
American Journal of Clinical Oncology|November 5, 1997
Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06R Komaki, C Scott, J S Lee, et al.
American Journal of Clinical Oncology|October 1, 1985
Characteristics of long-term survivors after treatment for inoperable carcinoma of the lungR Komaki, J D Cox, A J Hartz, et al.
American Journal of Clinical Oncology|April 1, 1992
Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04W T Sause, C Scott, S Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1989
Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trialJ R Simpson, M Bauer, C A Perez, et al.
Cancer|August 11, 1991
Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11W J Curran, J D Cox, N Azarnia, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1993
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433R Komaki, T F Pajak, R W Byhardt, et al.
Pageof 7